We recently published 10 Stocks Lost This Big While Wall Street Celebrates. Kenvue Inc. (NYSE:KVUE) is one of the worst performers on Monday. Shares of Kenvue Inc. (NYSE:KVUE) fell to a new all-time low after President Donald Trump linked autism to the use of Tylenol during pregnancy. During the session, shares of the company dropped to its lowest 52-week price of $16.89 before ending the day down by 7.47 percent at $16.97 apiece. 10 Best Cosmetic Surgery and Aesthetics Stocks To Buy Copyright: tomwang ...

Core Viewpoint - Global health officials and organizations have refuted claims linking acetaminophen to autism, emphasizing the lack of conclusive evidence despite recent statements from President Trump [1][6][9]. Company Response - Kenvue, the company behind Tylenol, asserts that independent research shows no causal link between acetaminophen and autism, expressing concern over the potential health risks and confusion for expecting mothers [3]. - Kenvue plans to continue advising expecting mothers to consult healthcare providers before taking any over-the-counter medications [3]. Regulatory Actions - The FDA has initiated a label change for acetaminophen in Tylenol, suggesting potential risks associated with its use during pregnancy, while still acknowledging that it may be reasonable for pregnant women to use it in certain situations [4][5]. - The FDA has recommended that pregnant women use the lowest effective dose for the shortest duration if necessary [6]. International Health Organizations' Stance - The European Medicines Agency and other global health organizations maintain that acetaminophen is safe for treating pain or fever in pregnant women, based on rigorous scientific assessments [7][9]. - The World Health Organization has stated that while some observational studies suggest a possible association between prenatal acetaminophen exposure and autism, the evidence remains inconsistent and lacks replicability [8][9]. Criticism of Misinformation - Spain's health minister criticized Trump's claims, highlighting the importance of relying on scientific evidence and health authorities rather than misinformation [9].

Market Overview - U.S. stock markets showed mixed performance on September 23, 2025, with the Dow Jones Industrial Average reaching new intraday records while the S&P 500 and Nasdaq Composite experienced slight declines [1][2] - The afternoon trading session reflected cautious sentiment as investors awaited remarks from Federal Reserve Chair Jerome Powell and upcoming inflation figures [1][2] Major Market Indexes - The Dow Jones Industrial Average (DJI) rose approximately 0.3% to 0.5%, reaching between 46,381 and 46,629 [2] - The S&P 500 (SPX) fell by 0.2% to 0.3%, settling around 6,693 points [2] - The Nasdaq Composite (COMP:IND) declined by 0.1% to 0.4%, trading between 22,726 and 22,788 [2] - Small-cap stocks, represented by the Russell 2000 (RUT), gained 0.6%, reaching new record highs due to optimism for rate cuts and improving domestic economic conditions [2] Sector Performance - The technology sector saw profit-taking, with Nvidia (NVDA) pulling back by 1.3% to 2.1% after a surge driven by a strategic partnership with OpenAI [3] - The aerospace and industrial sectors showed strength, with Boeing (BA) shares rising between 1.8% and 2.8% following Uzbekistan Airways' announcement to acquire Dreamliner aircraft [4] - Kenvue Inc. (KVUE) rebounded by 4.3% to 5.6% after a significant drop due to unsubstantiated claims linking Tylenol to autism [5] - Banking and gold stocks performed well, while retail stocks declined [6] - The energy sector saw gains, with the Philadelphia Oil Service Index up by 5.7% and the NYSE Arca Oil Index up by 2.9% [6] - Gold prices topped US$3,800 per ounce, rising approximately 45% year-to-date due to expectations of Federal Reserve rate cuts and inflation concerns [6] Economic Data and Federal Reserve Insights - The Flash U.S. Purchasing Managers' Index (PMI) for September indicated a slowdown in business activity growth, with the composite PMI falling to 53.6 from 54.6 in August [8] - Fed Chair Jerome Powell emphasized the challenges ahead regarding interest rates, with inflation risks tilted to the upside and employment risks to the downside [7] - Upcoming economic data includes the Personal Consumption Expenditures (PCE) Price Index, expected to show a slight acceleration in prices [9] Corporate Earnings and News - Major companies like Micron Technology (MU) and AutoZone (AZO) are set to report earnings, which could influence market sentiment [10] - Oracle (ORCL) appointed new co-CEOs, and Walt Disney Co. (DIS) saw a slight uptick in shares following a show reinstatement [11] - Spirit Airlines (SAVE) is preparing to furlough a significant portion of its flight attendants amid financial difficulties [11] - Google (GOOGL) plans to introduce an AI assistant for mobile gamers to enhance engagement on its platform [11]

Rising corporate earnings expectations are a bullish backdrop for stocks. According to Bloomberg Intelligence, more than 22% of companies in the S&P 500 provided guidance for their Q3 earnings results that are expected to beat analysts' expectations, the highest in a year. Also, S&P companies are expected to post +6.9% earnings growth in Q3, up from +6.7% as of the end of May.Fed Governor Michelle Bowman said, "Now that we have seen many months of deteriorating labor market conditions, it is time for the FO ...

Corporate Earnings - More than 22% of S&P 500 companies provided guidance for Q3 earnings that are expected to beat analysts' expectations, the highest in a year [1] - S&P companies are expected to post +6.9% earnings growth in Q3, an increase from +6.7% at the end of May [1] Federal Reserve and Economic Indicators - Fed Governor Michelle Bowman emphasized the need for decisive action from the FOMC due to deteriorating labor market conditions [2] - The US September S&P manufacturing PMI fell -1.0 to 52.0, weaker than the expected 52.2 [2] Current Account and Gold Prices - The US Q2 current account balance was -$251.3 billion, better than the expected -$256.6 billion [3] - Gold prices reached a new all-time high, up more than 1%, driven by dovish global central banks and geopolitical risks [3] Stock Market Performance - The Dow Jones Industrials posted a new all-time high, while the S&P 500 and Nasdaq 100 are consolidating after recent rallies [3] - Energy producers are performing well, with WTI crude oil prices up more than 1% [12] Stock Movers - Firefly Aerospace (FLY) is down more than -13% after reporting Q2 revenue of $15.5 million, below the consensus of $16.1 million [10] - Vistra Corp (VST) is down more than -4% following a downgrade by Jeffries [10] - Halliburton (HAL) is up more than +5% as energy producers gain [12] - Kenvue (KVUE) is up more than +6% after controversy surrounding Tylenol [13] Economic Data and Forecasts - August new home sales are expected to decline by -0.3% m/m to 650,000 [5] - August core capital goods new orders are expected to slip -0.1% m/m [5] - The markets are pricing in a 91% chance of a -25 bp rate cut at the next FOMC meeting [6]

Group 1 - U.S. stock market showed mixed results with Nasdaq down 0.04%, S&P 500 up 0.01%, and Dow Jones up 0.27% [1] - TSMC's stock rose over 3%, reaching a new high, with reports indicating a 20% price increase for the third-generation 3nm process compared to the previous generation, and a projected 50% price increase for the 2nm process to be supplied next year [1] - Boeing's stock increased by over 2% following an $8 billion order from Uzbekistan Airways, with Turkey also planning to purchase hundreds of American aircraft [1] Group 2 - Kenvue, the parent company of Tylenol, saw its stock rise over 7% after the WHO stated there is no consistent evidence linking prenatal exposure to acetaminophen with autism [1]

Core Insights - U.S. stock futures showed mixed signals as investors awaited key economic indicators and Federal Reserve Chair Jerome Powell's speech, following a strong session where major indices reached record highs driven by AI optimism and anticipated rate cuts [1][2]. Premarket Trading Activity and Futures Movements - Nasdaq 100 futures rose by 0.04%, while S&P 500 futures were up 0.01% and Dow futures increased by 0.07%, indicating a cautious sentiment among traders ahead of economic data releases [2]. Current Performance of Major Market Indexes - On Monday, the Nasdaq Composite rose 0.70% to close at 22,788.98, the S&P 500 climbed 0.44% to 6,693.75, and the Dow Jones Industrial Average increased by 0.14% to finish at 46,381.54, all achieving new closing highs [4]. Important Upcoming Market Events - Key events include Jerome Powell's speech on monetary policy and the release of flash PMI data, with a focus on the upcoming PCE price index, which is crucial for future policy decisions [5][6]. Major Stock News and Developments - Nvidia's shares surged approximately 4% following a $100 billion deal with OpenAI, while Apple Inc. saw a 4.3% increase due to strong iPhone 17 demand. Oracle Corp. climbed 6.3% after appointing new co-CEOs, and Boeing advanced 2.5% amid U.S.-China aircraft order negotiations [8][10]. - Pfizer announced its acquisition of Metsera for $4.9 billion, causing Metsera's stock to soar over 60%. Other notable movements included Kenvue rebounding 5.7%, Plug Power rising 6.65%, and Firefly Aerospace slumping 11% after financial results [11].

Group 1 - US stock index futures show mixed performance with Nasdaq futures down 0.04%, S&P 500 futures down 0.02%, and Dow futures up 0.16% [1] - European stock indices collectively rise, with Germany's DAX up 0.45%, UK's FTSE 100 up 0.18%, France's CAC up 0.97%, and Euro Stoxx 50 up 0.73% [2] - Goldman Sachs raises its year-end target for the S&P 500 index from 6600 to 6800 points [4] - Nvidia plans to invest up to $100 billion in OpenAI and co-develop AI data centers [5] - Meta's AI system Llama receives approval for use from the US government's General Services Administration (GSA) [6] - Alibaba's Qwen team is set to release six new items, including one product, two open-source models, and three API interfaces [7] - TSMC's third-generation 3nm process is rumored to increase prices by approximately 20%, while the 2nm process may see a 50% price increase [10] - Kenvue, the parent company of Tylenol, asserts that independent and reliable scientific evidence shows that acetaminophen does not cause autism [9] - Walmart expands its pharmacy delivery service to include home delivery of refrigerated prescription medications [11] - HSBC launches cross-border tokenized deposit services, with Ant International as its first client [12] - Kinsan Cloud plans to issue 282 million shares, with 80% of the raised funds allocated to support AI business [14] - Saudi Prince Alwaleed increases his stake in Snap by acquiring 15.2 million shares, raising his ownership to 2.8% [15]

Group 1: Technology and AI Investments - Nvidia plans to invest up to $100 billion in Microsoft-backed OpenAI to develop new AI data centers, highlighting its significant role in AI infrastructure [2] - Alibaba has launched its open-source large language model, Qwen3-Omni, which integrates text, image, audio, and video capabilities into a single model [3] Group 2: Aerospace Industry Developments - The U.S. and China are nearing a substantial Boeing aircraft order, potentially involving up to 500 aircraft, which could be Boeing's largest deal with China since 2017 [4] Group 3: Pharmaceutical Industry Concerns - The Trump administration has raised concerns about the use of Tylenol during pregnancy, suggesting a potential link to autism, although this claim lacks scientific backing [5][6] - Kenvue, the maker of Tylenol, maintains that the medication is safe, with estimates indicating it accounts for about 10% of the company's total revenue [7] - The warning regarding Tylenol could lead to increased lawsuits against Kenvue, which has faced around 500 lawsuits since 2022, although previous claims were dismissed due to insufficient evidence [8]

此外，英国卫生大臣韦斯.斯特里廷告诉英国患者，不要理会唐纳德.特朗普关于孕妇避免服用泰诺(在英 国称为扑热息痛)的呼吁，这是英国部长公开批评美国总统的罕见例子。 特朗普政府的警告可能导致针对Kenvue的诉讼增加，指控产前接触泰诺导致自闭症。 2023年从强生(JNJ.US)分拆出来的Kenvue自2022年以来已面临约500起此类诉讼。这些诉讼已在2023年 被驳回，当时一名联邦法官裁定无充分证据表明泰诺会导致自闭症。 花旗分析师表示，他们预计特朗普政府的警告对Kenvue构成的司法风险有限，"但负面新闻可能对泰诺 的销售产生一定影响"。虽然早期一些研究指出孕期服用泰诺与自闭症存在相关性，但2024年一项广泛 研究分析了瑞典近250万名儿童跨越25年的数据，最终结论两者间不存在关联。 智通财经APP注意到，泰诺生产商Kenvue(KVUE.US)股价周二盘前交易中上涨6%，该股昨日下跌 7.47%，此前特朗普政府警告孕期使用该公司生产的止痛药泰诺可能与自闭症有关。 值得注意的是，过去六个月因泰诺涉嫌与自闭症存在关联的指控频现，该股已累计下跌超四分之一。截 至发稿，Kenvue盘前涨6.01%，报17.99美 ...